Plain English Summary
An FDA-approved synthetic GHRH analog used medically to reduce excess belly fat (lipodystrophy) in HIV patients. Also researched for cognitive benefits and general fat loss.
What People Use It For
Realistic Expectations
Best Case
Meaningful reduction in visceral fat and improved body composition over 26 weeks.
Common Outcome
Modest fat loss and subtle cognitive benefits; requires consistent use.
Low / No Response
Minimal visible change; depends heavily on diet and baseline GH levels.
Side Effects & Risks
Common Side Effects
Warnings
- FDA approved only for HIV-associated lipodystrophy
- Off-label use is not regulated
- May worsen diabetes or pre-diabetes
Who This Is Not For
People with active malignancies, pregnancy, or disrupted hypothalamic-pituitary axis.
Commonly Confused With
Timeline of Expected Changes
Clinical trials show effects at 26 weeks; some users report changes at 8–12 weeks.
Researchers also explore
Tesamorelin
Tesamorelin is an FDA-approved synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce natural growth hormone. It is best known for significantly reducing visceral (abdominal) fat and is the only peptide in its class with an FDA approval for HIV-associated lipodystrophy. Researchers also study it for cognitive enhancement via IGF-1 elevation and its potential to reduce liver fat.
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most effective weight loss medications available. It works by mimicking a natural hormone that regulates appetite and blood sugar, helping people feel full faster and longer.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even stronger weight loss results than semaglutide in clinical trials. It targets two hormone pathways instead of one, making it potentially more effective for both weight loss and blood sugar control.
GIP (Glucose-dependent Insulinotropic Polypeptide)
GIP is an endogenous incretin hormone released from the gut after nutrient intake. It plays a critical role in glucose metabolism by stimulating insulin secretion in a glucose-dependent manner. While historically studied for its insulinotropic effects, modern research focuses on its systemic roles in adipose tissue, bone remodeling, and the central nervous system, particularly when combined with GLP-1 for metabolic therapies.
Researcher Sentiment
No votes yet — be the first
Educational Content Only
This is not medical advice. Always consult a licensed healthcare provider before using any compound. No dosing or sourcing guidance is provided.